7th EFMC-YSN MedChemBioOnline

Epigenetics: The Road Towards a Polypharmacological Approach

 Virtual Event    May 25, 2021

Dr Clemens Zwergel (Sapienza University of Rome, Italy)

Dr Caroline Lanthier (University of Antwerp, Belgium)


  • 17:00 | Opening
  • 17:05 | Development of Epigenetic Dual-targeting Inhibitors as a New Strategy for Fighting Cancer
    Prof. Sergio Valente (Sapienza University of Rome, Italy) 
  • 17:50 | Enabling Epigenetic Drug Discovery Through Quality Proteins and Assay Services
    Dr Ekaterina Kuznetsova (Reaction Biology, US)
  • 18:00 | Publishing Ethics: Best Practices in Writing Manuscripts
    David Peralta (Editor-in-Chief, ChemMedChem, A Chemistry Europe Journal)
  • 18:45 | Round Table Discussion: "Epigenetics the Road Ahead: Are Polypharmacology and Epitranscriptomics our Bright Future?“
    Prof. Paul Brennan (University of Oxford, United Kingdom) 
    Prof. Sergio Valente (Sapienza University of Rome, Italy)
    Dr Haiching Ma (Reaction Bilogy, United States) 
    Prof. Olalla Vazquez (Philipps-University Marburg, Germany) 
    Panelist to be announced
  • 19:15 | End of the event

The event is free and open to all thanks to the generous support of Reaction Biology

Reaction Biology is an industry leader offering contract research for epigenetic drug discovery. We have a reputation for providing high quality data generated by gold standard activity and binding assays. Via flexibility for custom-tailored solutions and direct communication with our clients we address the goals of every individual research project.